High Hemoglobin Levels and Polycythemia as Markers of Cardiometabolic Risk and Metabolic Syndrome in Adults: A Focused Systematic Review and Evidence Update Through August 2026

Main Article Content

Dony Prasetya Nugraha
Rumah Sakit Pertamina Tarakan
Alvin T Harahap
Rumah Sakit Pusat Pertamina

Metabolic syndrome (MetS) increases the risk of type 2 diabetes mellitus and cardiovascular disease. Although hemoglobin concentration is routinely measured in clinical practice, its utility as an indicator of cardiometabolic risk remains uncertain. This systematic review examined the associations between elevated hemoglobin concentrations, including high-normal levels and polycythemia, and MetS and cardiometabolic outcomes in adults, with particular attention to temporal patterns and differences by sex and age. A systematic literature search was conducted in PubMed/MEDLINE, PubMed Central, and ScienceDirect for studies published between 2013 and August 22, 2026, supplemented by citation tracking. Risk of bias was assessed qualitatively, and findings were synthesized narratively because of heterogeneity in exposure and outcome definitions and overlapping study cohorts. Eighteen publications representing approximately 15 distinct cohorts were included. Higher hemoglobin concentrations were generally associated with a greater prevalence of MetS and less favorable adiposity, blood pressure, lipid, and glycemic profiles. Among middle-aged Japanese men, polycythemia was associated with significantly higher odds of MetS (adjusted odds ratio [aOR] = 2.39; 95% confidence interval [CI]: 2.02–2.85). Longitudinal studies also identified associations between higher hemoglobin concentrations and incident MetS, although the magnitude and direction of these associations varied by sex and age. Population-based biobank analyses revealed U-shaped associations between hemoglobin concentrations and diabetes risk, highlighting potential nonlinear relationships. Overall, hemoglobin concentration may serve as a complementary marker in cardiometabolic risk assessment. However, the available evidence remains insufficient to establish causality or justify its use as a standalone screening biomarker. Further prospective studies and external validation are needed to determine whether hemoglobin provides incremental predictive value beyond established cardiometabolic risk factors.


Keywords: Hemoglobin, Polycythemia, Metabolic Syndrome, Cardiometabolic Risk, Insulin Resistance, Systematic Review
Ahmadzadeh, J., Mansorian, B., Mirza-Aghazadeh Attari, M., Mohebbi, I., Naz-Avar, R., Moghadam, K., & Khoshbou Ghareh-bagh, S. A. (2018). The association between hematological parameters and metabolic syndrome in Iranian men: A single center large-scale study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 12(1), 17-21. https://doi.org/10.1016/j.dsx.2017.07.044
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C., Jr. (2009). Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120(16), 1640-1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
Auvinen, J., Tapio, J., Karhunen, V., Kettunen, J., Serpi, R., Dimova, E. Y., Gill, D., Soininen, P., Tammelin, T., Mykkanen, J., Puukka, K., Kahonen, M., Raitoharju, E., Lehtimaki, T., Ala-Korpela, M., Raitakari, O. T., Keinanen-Kiukaanniemi, S., Jarvelin, M.-R., & Koivunen, P. (2021). Systematic evaluation of the association between hemoglobin levels and metabolic profile implicates beneficial effects of hypoxia. Science Advances, 7(29), Article eabi4822. https://doi.org/10.1126/sciadv.abi4822
Dutt, S., Hamza, I., & Bartnikas, T. B. (2022). Molecular mechanisms of iron and heme metabolism. Annual Review of Nutrition, 42, 311-335. https://doi.org/10.1146/annurev-nutr-062320-112625
Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022). Metabolic syndrome: Updates on pathophysiology and management in 2021. International Journal of Molecular Sciences, 23(2), Article 786. https://doi.org/10.3390/ijms23020786
Gassner, J., Norha, J., Sjoros, T., Garthwaite, T., Koivula, T., Laine, S., Koivumaki, M., Vaha-Ypya, H., Kallio, P., Saarenhovi, M., Loyttyniemi, E., Sievanen, H., Houttu, N., Laitinen, K., Kalliokoski, K. K., Vasankari, T., Koivunen, P., Knuuti, J., & Heinonen, I. (2026). Changes in hemoglobin levels and cardiometabolic health in adults with metabolic syndrome-A secondary outcome analysis of a six-month randomized controlled trial. Annals of Medicine, 58(1), Article 2635205. https://doi.org/10.1080/07853890.2026.2635205
Gyawali, P., Richards, R. S., Hughes, D. L., & Tinley, P. (2014). Erythrocyte aggregation and metabolic syndrome. Clinical Hemorheology and Microcirculation, 57(1), 73-83. https://doi.org/10.3233/CH-131792
Hashimoto, Y., Tanaka, M., Kimura, T., Kitagawa, N., Hamaguchi, M., Asano, M., Yamazaki, M., Oda, Y., Toda, H., Nakamura, N., & Fukui, M. (2015). Hemoglobin concentration and incident metabolic syndrome: A population-based large-scale cohort study. Endocrine, 50(2), 390-396. https://doi.org/10.1007/s12020-015-0587-9
He, S., Gu, H., Yang, J., Su, Q., Li, X., & Qin, L. (2021). Hemoglobin concentration is associated with the incidence of metabolic syndrome. BMC Endocrine Disorders, 21(1), Article 53. https://doi.org/10.1186/s12902-021-00719-4
Kawamoto, R., Tabara, Y., Kohara, K., Miki, T., Kusunoki, T., Abe, M., & Katoh, T. (2013). Hematological parameters are associated with metabolic syndrome in Japanese community-dwelling persons. Endocrine, 43(2), 334-341. https://doi.org/10.1007/s12020-012-9662-7
Laudisio, A., Bandinelli, S., Gemma, A., Ferrucci, L., & Antonelli Incalzi, R. (2013). Metabolic syndrome and hemoglobin levels in elderly adults: The Invecchiare in Chianti Study. Journal of the American Geriatrics Society, 61(6), 963-968. https://doi.org/10.1111/jgs.12256
Li, N., Liu, C., Luo, Q., Zhang, F., Sheng, D., & Liu, Z. (2023). Correlation of white blood cell, neutrophils, and hemoglobin with metabolic syndrome and its components. Diabetes, Metabolic Syndrome and Obesity, 16, 1347-1355. https://doi.org/10.2147/DMSO.S408081
Liu, J., Gou, Y., Yang, W., Wang, H., Zhang, J., Wu, S., Liu, S., Tao, T., Tang, Y., & Yang, C. (2025). Development and application of machine learning models for hematological disease diagnosis using routine laboratory parameters: a user-friendly diagnostic platform. Frontiers in Medicine, 12, 1605868.
Mahmood, A., Samad, S., Haider, H., Hassan, W., Mushtaq, R., Perwaiz, A., Ali, A., & Azharuddin, M. (2024). Association of red blood cell and platelet parameters with metabolic syndrome: A systematic review and meta-analysis of 170,000 patients. Hormone and Metabolic Research, 56(7), 517-525. https://doi.org/10.1055/a-2241-5361
Minato, S., Takenouchi, A., Uchida, J., Tsuboi, A., Kurata, M., Fukuo, K., & Kazumi, T. (2017). Association of whole blood viscosity with metabolic syndrome in type 2 diabetic patients: Independent association with post-breakfast triglyceridemia. Journal of Clinical Medicine Research, 9(4), 332-338. https://doi.org/10.14740/jocmr2885w
Najafzadeh, M. J., Baniasad, A., Shahabinejad, R., Mashrooteh, M., Najafipour, H., & Gozashti, M. H. (2023). Investigating the relationship between haematological parameters and metabolic syndrome: A population-based study. Endocrinology, Diabetes & Metabolism, 6(2), e407.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hrobjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., . . . Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, Article n71. https://doi.org/10.1136/bmj.n71
Park, J. M. (2026). Association of hemoglobin levels with metabolic syndrome and its components in older Korean males: A nationwide population-based cross-sectional study. Medicine, 105(24), Article e49342. https://doi.org/10.1097/MD.0000000000049342
Qiu, F., Wu, L., Yang, G., Zhang, C., Liu, X., Sun, X., Chen, X., & Wang, N. (2022). The role of iron metabolism in chronic diseases related to obesity. Molecular Medicine, 28, Article 130. https://doi.org/10.1186/s10020-022-00558-6
Tanaka, M., Okada, H., Hashimoto, Y., Kumagai, M., Nishimura, H., & Fukui, M. (2020). Combined effect of hemoglobin and mean corpuscular volume levels on incident metabolic syndrome: A population-based cohort study. Clinical Nutrition ESPEN, 40, 314-319. https://doi.org/10.1016/j.clnesp.2020.08.010
Tapio, J., Vahanikkila, H., Kesaniemi, Y. A., Ukkola, O., & Koivunen, P. (2021). Higher hemoglobin levels are an independent risk factor for adverse metabolism and higher mortality in a 20-year follow-up. Scientific Reports, 11(1), Article 19936. https://doi.org/10.1038/s41598-021-99217-9
Timoteo, V. J., Chiang, K. M., & Pan, W. H. (2022). Positive or U-shaped association of elevated hemoglobin concentration levels with metabolic syndrome and metabolic components: Findings from Taiwan Biobank and UK Biobank. Nutrients, 14(19), Article 4007. https://doi.org/10.3390/nu14194007
Tokugawa, T., Sawada, A., Higasa, S., & Wakabayashi, I. (2025). Associations between blood hemoglobin concentrations and cardiometabolic risk in middle-aged women. Women's Health Reports, 6(1), 80-89. https://doi.org/10.1089/whr.2024.0140
Wakabayashi, I. (2022). Associations between polycythemia and cardiometabolic risk factors in middle-aged men. Clinica Chimica Acta, 531, 248-253. https://doi.org/10.1016/j.cca.2022.04.009
Wakabayashi, I. (2023). Effects of age on polycythemia, cardiometabolic risk and their associations in middle-aged men. Journal of Diabetes & Metabolic Disorders, 22(1), 287-295. https://doi.org/10.1007/s40200-022-01130-z
Wakabayashi, I., & Daimon, T. (2023). Hematometabolic index as a new discriminator of cardiometabolic risk in middle-aged men with polycythemia and high leukocyte count in peripheral blood. Metabolic Syndrome and Related Disorders, 21(5), 267-274. https://doi.org/10.1089/met.2023.0011
Wakabayashi, I., Nakano, T., Goto, K., Daimon, T., & Ishii, K. (2025). Prognostic value of the hematometabolic index for incident metabolic syndrome: Findings from a large occupational cohort of Japanese men. Cureus, 17, Article e98288. https://doi.org/10.7759/cureus.98288
Wu, S., Lin, H., Zhang, C., Zhang, Q., Zhang, D., Zhang, Y., Meng, W., Zhu, Z., Tang, F., Xue, F., & Liu, Y. (2013). Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: A longitudinal cohort study. BMC Public Health, 13, Article 989. https://doi.org/10.1186/1471-2458-13-989